Ventas Reports 2026 Second Quarter Results

CHICAGO, July 29, 2026--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today reported results for the second quarter ended June 30, 2026.

CEO Remarks

"Ventas's momentum continued in the second quarter. We delivered strong enterprise results, executing on our strategy to capture the unprecedented opportunity in senior housing through powerful organic and external growth in our Senior Housing Operating Portfolio," said Debra A. Cafaro, Ventas Chairman and CEO. "Demographic demand is strong and getting stronger as the baby boomers begin turning 80 this year. Meanwhile, new supply remains at historic lows, setting up a compelling multiyear runway for growth and value creation.

"Our portfolio and platform are built to meet this moment, and we continue to expand our senior housing footprint," Cafaro continued. "We are increasing our 2026 investment volume expectations to $4.5 billion, after completing over $3 billion of attractive U.S. senior housing investments year to date and growing our active, actionable investment pipeline. Our differentiated platform, experience, industry relationships and scale are competitive advantages driving Ventas's outperformance and elevating our industry to better serve a large and growing aging population.

"We are again raising our full year earnings guidance primarily because of our increased investment activity. The Ventas team remains focused on winning together and delivering for our stakeholders as we enable exceptional environments that help people live longer, healthier, happier lives," Cafaro concluded.

Second Quarter and Other 2026 Highlights

Net Income Attributable to Common Stockholders ("Attributable Net Income") per share of $0.14

Normalized Funds From Operations* ("Normalized FFO") per share of $0.97, an increase of 9% year-over-year

Total Company Net Operating Income* ("NOI") year-over-year growth of 17% and Total Company Same-Store Cash NOI* year-over-year growth of 10%

On a Same-Store Cash NOI* basis, the senior housing operating portfolio ("SHOP") grew 16% year-over-year, with Same-Store Cash Operating Revenue* growth of 9% and Same-Store Cash NOI margin* growth of 210 basis points

Year to date, the Company closed $3.4 billion of investments focused on senior housing with attractive financial return expectations, consistent with its Right Market, Right Asset, Right OperatorTM strategy

To fund its 2026 investment activity, the Company settled 31.4 million shares of common stock under equity forward sales agreements year to date for gross proceeds of $2.6 billion, and currently has $1.6 billion of unsettled equity forward sales agreements, totaling $4.2 billion in equity capital

Story Continues

*Some of the financial measures throughout this press release are non-GAAP measures. Refer to the Non-GAAP Financial Measures Reconciliation tables at the end of this press release for additional information and a reconciliation to the most directly comparable GAAP measure.

Second Quarter 2026 Company Results

For the Second Quarter 2026, reported per share results were:

Quarter Ended June 30, 2026 2025 $ Change % Change Attributable Net Income $0.14 $0.15 ($0.01) (7%) Nareit FFO* $0.99 $0.86 $0.13 15% Normalized FFO* $0.97 $0.89 $0.08 9%

SHOP Growth

In the second quarter, SHOP Same-Store Cash NOI increased 16% year-over-year, led by Same-Store Cash Operating Revenue growth of 9% and 210 basis points of Same-Store Cash NOI margin expansion. Same-Store Cash Operating Revenue growth of 9% included revenue per occupied room ("RevPOR") growth of 5% and average occupancy growth of 300 basis points year-over-year.

U.S. SHOP Same-Store Cash NOI increased 18% year-over-year and average occupancy grew 360 basis points year-over-year.

Investment Activity

Ventas closed $2.2 billion of investments focused on senior housing in the second quarter and $3.4 billion year to date. The Company expects these investments to increase its growth rate on a multiyear basis and generate attractive financial returns.

The Company is increasing its investment volume expectations for 2026 to $4.5 billion of investments focused on senior housing, up from the prior guidance of $3 billion.

Financial Strength and Flexibility

The Company's Net Debt-to-Further Adjusted EBITDA* strengthened to 4.7x as of the end of the second quarter, representing nearly a full turn improvement from the prior year. The improvement was driven by SHOP NOI growth and equity-funded senior housing investments.

As of June 30, 2026, the Company had $4.9 billion in liquidity, supporting Ventas's growth and financial flexibility. Liquidity includes availability under its unsecured credit facilities, cash and cash equivalents and unsettled equity forward sales agreements outstanding.

Increased Full Year 2026 Guidance

The Company is increasing its guidance for the full year. The Company's 2026 guidance contains forward-looking statements and is based on a number of assumptions, including those identified later in this press release; actual results may differ materially. Ventas expects to report 2026 per share Attributable Net Income, Nareit FFO and Normalized FFO within the following ranges:

As of 4/27/26 As of 7/29/26 Attributable Net Income Per Share Range $0.56 - $0.63 $0.58 - $0.63 Attributable Net Income Per Share Midpoint $0.60 $0.61 Nareit FFO Per Share Range* $3.69 - $3.76 $3.76 - $3.81 Nareit FFO Per Share Midpoint* $3.73 $3.79 Normalized FFO Per Share Range* $3.82 - $3.89 $3.85 - $3.90 Normalized FFO Per Share Midpoint* $3.86 $3.88

Full Year 2026 Guidance Commentary Update

The increase in the Company's guidance is primarily the result of increased accretive senior housing investment activity. Certain additional assumptions are set forth in the appendix.

Investor Presentation

An Earnings Presentation is posted to the Events & Presentations section of Ventas's website at ir.ventasreit.com/events-and-presentations. Additional information regarding the Company can be found in its Supplemental posted at ir.ventasreit.com. The information contained on, or that may be accessed through, the Company's website, including the information contained in the aforementioned Earnings Presentation and Supplemental, is not incorporated by reference into, and is not part of, this document.

Second Quarter 2026 Results Conference Call

Ventas will hold a conference call to discuss this earnings release on Thursday, July 30, 2026 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time).

The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can be accessed from the Investor Relations section of www.ventasreit.com.

A telephonic replay will be available at (800) 770-2030 (or +1 (609) 800-9909 for international callers), passcode 7655497, after the earnings call and will remain available for 30 days. The webcast replay will be posted in the Investor Relations section of www.ventasreit.com.

About Ventas

Ventas, Inc. (NYSE: VTR) is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its more than 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas's seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.

Non-GAAP Financial Measures

This press release of Ventas, Inc. (the "Company," "we," "us," "our" and similar terms) includes certain financial performance measures not defined by generally accepted accounting principles in the United States ("GAAP"), such as Nareit FFO, Normalized FFO, Net Operating Income ("NOI"), Same-Store Cash NOI, Same-Store Cash NOI Growth, Same-Store Cash NOI Margin, Cash Operating Revenue and Net Debt to Further Adjusted EBITDA. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures are included in the appendix to this press release. Our definitions and calculations of these non-GAAP measures may not be the same as similar measures reported by other REITs.

These non-GAAP financial measures should not be considered as alternatives for, or superior to, financial measures calculated in accordance with GAAP.

Cautionary Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, among others, statements of expectations, beliefs, future plans and strategies, anticipated results from operations and developments and other matters that are not historical facts. Forward-looking statements include, among other things, statements regarding our and our officers' intent, belief or expectation as identified by the use of phrases or words such as "assume," "may," "will," "project," "expect," "believe," "intend," "anticipate," "seek," "target," "forecast," "plan," "line-of-sight," "outlook," "potential," "opportunity," "estimate," "could," "would," "should" and other comparable and derivative terms or the negatives thereof.

Forward-looking statements are based on management's beliefs as well as on a number of assumptions concerning future events. You should not put undue reliance on these forward-looking statements, which are not a guarantee of performance and are subject to a number of uncertainties and other factors that could cause actual events or results to differ materially from those expressed or implied by the forward-looking statements. We do not undertake a duty to update these forward-looking statements, which speak only as of the date on which they are made. We urge you to carefully review the disclosures we make concerning risks and uncertainties that may affect our business and future financial performance, including those made below and in our filings with the Securities and Exchange Commission, such as in the sections titled "Cautionary Statements — Summary Risk Factors" and "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2025, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our subsequent Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K as we file them with the Securities and Exchange Commission.

Certain factors that could affect our future results and our ability to achieve our stated goals include, but are not limited to: (a) our exposure and the exposure of our managers, tenants and borrowers to complex and evolving governmental policy, laws and regulations, including relating to healthcare, data privacy, cybersecurity, artificial intelligence, international trade and environmental matters, the impact of such policies, laws and regulations on our and our managers', tenants' and borrowers' business and the challenges and expense associated with complying with such policies, laws and regulations; (b) the impact of market, macroeconomic and general economic conditions on us, our managers, tenants and borrowers and in areas in which our properties are geographically concentrated, including changes in or elevated inflation, interest rates and exchange rates, labor market dynamics and rises in unemployment, tightening of lending standards and reduced availability of credit or capital, events that affect consumer confidence, and the actual and perceived state of the real estate markets and public and private capital markets; (c) our ability, and the ability of our managers, tenants and borrowers, to navigate the trends impacting our or their businesses and the industries in which we or they operate, including their ability to respond to the impact of the U.S. political environment on government funding and reimbursement programs, and the financial condition or business prospect of our managers, tenants and borrowers; (d) our ability to achieve the anticipated benefits and synergies from, and effectively integrate, our completed or anticipated acquisitions and investments; (e) our ability to identify and consummate future investments in healthcare assets and effectively manage our portfolio opportunities and our investments in co-investment vehicles, joint ventures and minority interests; (f) the potential for significant general and commercial claims, legal actions, investigations, regulatory proceedings and enforcement actions that could subject us or our managers, tenants or borrowers to increased operating costs, uninsured liabilities, including fines and other penalties, reputational harm or significant operational limitations, including the loss or suspension of or moratoriums on accreditations, licenses or certificates of need, suspension of or nonpayment for new admissions, denial of reimbursement, suspension, decertification or exclusion from federal, state or foreign healthcare programs or the closure of facilities or communities; (g) our reliance on third-party managers and tenants to operate or exert substantial control over properties they manage for, or lease from, us, which limits our control and influence over such properties, their operations and their performance; (h) our reliance and the reliance of our managers, tenants and borrowers on the financial, credit and capital markets and the risk that those markets may be disrupted or become constrained; (i) the risk of bankruptcy, inability to obtain benefits from governmental programs, insolvency or financial deterioration of our managers, tenants, borrowers and other obligors which may, among other things, have an adverse impact on the ability of such parties to make payments or meet their other obligations to us; (j) our dependency on a limited number of managers and tenants for a significant portion of our revenues and operating income; (k) our exposure to various operational risks, liabilities and claims from our operating assets; (l) our exposure to particular risks due to our specific asset classes and operating markets, such as adverse changes affecting our specific asset classes and the healthcare real estate sector, the competitiveness or financial viability of hospitals on or near the campuses where our outpatient medical buildings are located, our relationships with universities, the level of expense and uncertainty of our research tenants, and the limitation of our uses of some properties we own that are subject to ground lease, air rights or other restrictive agreements; (m) our ownership of properties or operation of business outside of the U.S. that may subject us to different or greater risks than those associated with our domestic operations; (n) the risk that our management agreements or leases are not renewed or are renewed on less favorable terms, that our managers or tenants default under those agreements or that we are unable to replace managers or tenants on a timely basis or on favorable terms, if at all; (o) the risk that the borrowers under our loans or other investments default or that, to the extent we are able to foreclose or otherwise acquire the collateral securing our loans or other investments, we will be required to incur additional expense or indebtedness in connection therewith, that the assets will underperform expectations or that we may not be able to subsequently dispose of all or part of such assets on favorable terms; (p) risks related to the recognition of reserves, allowances, credit losses or impairment charges which are inherently uncertain and may increase or decrease in the future and may not represent or reflect the ultimate value of, or loss that we ultimately realize with respect to, the relevant assets; (q) the risk of exposure to unknown liabilities from our investments in properties or businesses; (r) the impact of merger, acquisition and investment activity in the healthcare industry or otherwise affecting our managers, tenants or borrowers; (s) risks related to development, redevelopment and construction projects, including costs associated with inflation, rising or elevated interest rates, labor conditions and supply chain pressures, and risks related to increased construction and development in markets in which our properties are located, including adverse effect on our future occupancy rates; (t) our current and future amount of outstanding indebtedness, and our ability to access capital and to incur additional debt which is subject to our compliance with covenants in instruments governing our and our subsidiaries' existing indebtedness; (u) increases in our borrowing costs as a result of becoming more leveraged, including in connection with acquisitions or other investment activity and rising or elevated interest rates; (v) the risk of potential dilution resulting from future sales or issuances of our equity securities; (w) the availability, adequacy and pricing of insurance coverage provided by our policies and policies maintained by our managers, tenants, borrowers or other counterparties; (x) the risks or uncertainties relating to the use of, or inability to take advantage of, the benefits of artificial intelligence by us or our managers, tenants or borrowers; (y) the occurrence of cybersecurity threats and incidents that could disrupt our or our managers', tenants' or borrower's operations, result in the loss of confidential or personal information or damage our business relationships and reputation; (z) the risk of catastrophic or extreme weather and other natural events; (aa) our ability to attract and retain talented employees; (bb) our ability to maintain a positive reputation for quality and service with our key stakeholders; (cc) the limitations and significant requirements imposed upon our business as a result of our status as a REIT and the adverse consequences (including the possible loss of our status as a REIT) that would result if we are not able to comply with such requirements; (dd) the ownership limits contained in our certificate of incorporation with respect to our capital stock in order to preserve our qualification as a REIT, which may delay, defer or prevent a change of control of our company; and (ee) the other factors set forth in our periodic filings with the Securities and Exchange Commission.

CONSOLIDATED BALANCE SHEETS (In thousands, except per share amounts; dollars in USD; unaudited) As of June 30, 2026 As of December 31, 2025 Assets Real estate investments: Land and improvements $ 3,260,895 $ 2,962,738 Buildings and improvements 33,346,737 30,872,598 Construction in progress 253,902 358,811 Acquired lease intangibles 1,937,522 1,680,567 Operating lease assets 316,707 295,838 39,115,763 36,170,552 Accumulated depreciation and amortization (12,622,838 ) (12,043,619 ) Net real estate property 26,492,925 24,126,933 Secured loans receivable and investments, net 436,401 143,913 Investments in unconsolidated real estate entities 590,630 617,571 Net real estate investments 27,519,956 24,888,417 Cash and cash equivalents 198,956 741,067 Escrow deposits and restricted cash 24,861 45,070 Goodwill 1,045,816 1,046,072 Assets held for sale 28,744 42,993 Deferred income tax assets, net 3,134 2,797 Other assets 834,429 825,529 Total assets $ 29,655,896 $ 27,591,945 Liabilities and equity Liabilities: Senior notes payable and other debt $ 12,687,789 $ 13,011,016 Accrued interest payable 142,464 143,104 Operating lease liabilities 231,210 208,602 Accounts payable and other liabilities 1,349,477 1,240,820 Liabilities related to assets held for sale 2,584 4,032 Deferred income tax liabilities 30,739 23,409 Total liabilities 14,444,263 14,630,983 Redeemable OP unitholder and noncontrolling interests 509,069 375,154 Commitments and contingencies Equity: Ventas stockholders' equity: Preferred stock, $1.00 par value; 10,000 shares authorized, unissued — — Common stock, $0.25 par value; 1,200,000 shares authorized, 512,946 and 474,926 shares outstanding at June 30, 2026 and December 31, 2025, respectively 128,237 118,732 Capital in excess of par value 22,478,217 19,976,183 Accumulated other comprehensive loss (31,510 ) (39,851 ) Retained earnings (deficit) (7,925,545 ) (7,527,777 ) Treasury stock, 0 shares issued — (34 ) Total Ventas stockholders' equity 14,649,399 12,527,253 Noncontrolling interests 53,165 58,555 Total equity 14,702,564 12,585,808 Total liabilities and equity $ 29,655,896 $ 27,591,945

CONSOLIDATED STATEMENTS OF INCOME (In thousands, except per share amounts; dollars in USD; unaudited) For the Three Months Ended

June 30, For the Six Months Ended

June 30, 2026 2025 2026 2025 Revenues Rental income: Triple-net leased properties $ 124,856 $ 152,702 $ 247,927 $ 308,815 Outpatient medical and research portfolio 228,605 220,814 458,709 442,133 353,461 373,516 706,636 750,948 Resident fees and services 1,363,498 1,032,714 2,656,288 2,001,618 Third-party capital management revenues 4,245 4,397 8,656 8,733 Income from loans and investments 6,632 4,395 10,701 8,719 Interest and other income 1,778 5,871 4,277 8,949 Total revenues 1,729,614 1,420,893 3,386,558 2,778,967 Expenses Interest 160,034 150,298 316,176 299,654 Depreciation and amortization 407,711 347,719 790,179 669,244 Property-level operating expenses: Senior housing 959,999 746,302 1,878,331 1,450,702 Outpatient medical and research portfolio 77,781 75,001 158,082 150,958 Triple-net leased properties 3,142 3,966 6,043 7,493 1,040,922 825,269 2,042,456 1,609,153 Third-party capital management expenses 1,706 1,627 3,539 3,452 General, administrative and professional fees 46,986 42,856 109,732 96,005 Loss on extinguishment of debt, net 83 — 532 — Transaction, transition and restructuring costs 13,478 4,627 20,137 10,609 Other expense 4,454 5,839 14,154 7,251 Total expenses 1,675,374 1,378,235 3,296,905 2,695,368 Income before unconsolidated entities, real estate dispositions, income taxes and noncontrolling interests 54,240 42,658 89,653 83,599 Loss from unconsolidated entities (7,812 ) (1,138 ) (15,162 ) (4,449 ) Gain on real estate dispositions 176 33,816 15,222 33,985 Income tax benefit (expense) 25,618 (3,874 ) 41,555 6,683 Net income 72,222 71,462 131,268 119,818 Net income attributable to noncontrolling interests 1,652 3,198 4,786 4,686 Net income attributable to common stockholders $ 70,570 $ 68,264 $ 126,482 $ 115,132 Earnings per common share Basic: Net income $ 0.15 $ 0.16 $ 0.27 $ 0.27 Net income attributable to common stockholders 0.14 0.15 0.26 0.26 Diluted: Net income $ 0.15 $ 0.16 $ 0.27 $ 0.26 Net income attributable to common stockholders 0.14 0.15 0.26 0.25 Weighted average shares used in computing earnings per common share Basic 489,287 452,583 482,802 446,314 Diluted 497,724 459,088 492,282 453,000

NON-GAAP FINANCIAL MEASURES RECONCILIATION

Funds From Operations Attributable to Common Stockholders (FFO)

(In thousands, except per share amounts; dollars in USD; totals may not sum due to rounding; unaudited) For the Three Months

Ended June 30, Q2 YoY Change 2026 2025 '26-'25 Net income attributable to common stockholders $ 70,570 $ 68,264 3% Net income attributable to common stockholders per share $ 0.14 $ 0.15 (7%) Adjustments: Depreciation and amortization on real estate assets 406,036 346,214 Depreciation on real estate assets related to noncontrolling interests (6,238 ) (3,973 ) Depreciation on real estate assets related to unconsolidated entities 22,600 18,716 Gain on real estate dispositions (176 ) (33,816 ) Loss (gain) on real estate dispositions related to unconsolidated entities 29 (62 ) Subtotal: Nareit FFO adjustments 422,251 327,079 Subtotal: Nareit FFO adjustments per share $ 0.85 $ 0.71 Nareit FFO attributable to common stockholders $ 492,821 $ 395,343 25% Nareit FFO attributable to common stockholders per share $ 0.99 $ 0.86 15% Adjustments: Loss (gain) on derivatives, net 100 (1,074 ) Non-cash impact of income tax (benefit) expense (29,017 ) 748 Loss on extinguishment of debt, net 83 — Transaction, transition and restructuring costs 13,478 4,627 Amortization of other intangibles 119 121 Non-cash stock-based compensation expense (1) 5,312 7,683 Significant disruptive events, net (1,064 ) 958 Normalizing items related to noncontrolling interests and unconsolidated entities, net 1,884 463 Other normalizing items, net — (1 ) Subtotal: Normalized FFO adjustments (9,105 ) 13,525 Subtotal: Normalized FFO adjustments per share $ (0.02 ) $ 0.03 Normalized FFO attributable to common stockholders (1) $ 483,716 $ 408,868 18% Normalized FFO attributable to common stockholders per share $ 0.97 $ 0.89 9% Weighted average diluted shares 497,724 459,088

(1) Beginning with the first quarter of 2026, the Company excludes non-cash stock-based compensation expense from the calculation of Normalized FFO. Results for prior periods have been updated to conform to this presentation.

Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time. However, since real estate values historically have risen or fallen with market conditions, many industry investors deem presentations of operating results for real estate companies that use historical cost accounting to be insufficient by themselves. For that reason, the Company considers Funds From Operations attributable to common stockholders ("FFO") and Normalized FFO attributable to common stockholders ("Normalized FFO") to be appropriate supplemental measures of operating performance of an equity REIT. The Company believes that the presentation of FFO, combined with the presentation of required GAAP financial measures, has improved the understanding of operating results of REITs among the investing public and has helped make comparisons of REIT operating results more meaningful. Management generally considers FFO to be a useful measure for understanding and comparing our operating results because, by excluding gains and losses related to sales of previously depreciated operating real estate assets, impairment losses on depreciable real estate and real estate asset depreciation and amortization (which can differ across owners of similar assets in similar condition based on historical cost accounting and useful life estimates), FFO can help investors compare the operating performance of a company's real estate across reporting periods and to the operating performance of other companies. The Company believes that Normalized FFO is useful because it allows investors, analysts and Company management to compare the Company's operating performance across periods on a consistent basis. In some cases, the Company provides information about identified non-cash components of FFO and Normalized FFO because it allows investors, analysts and our management to assess the impact of those items on our financial results.

Nareit Funds From Operations Attributable to Common Stockholders ("Nareit FFO")

The Company uses the National Association of Real Estate Investment Trusts ("Nareit") definition of FFO. Nareit defines FFO as net income attributable to common stockholders (computed in accordance with GAAP) excluding gains (or losses) from sales of real estate property, including gain (or loss) on re-measurement of equity method investments and impairment write-downs of depreciable real estate, plus real estate depreciation and amortization, and after adjustments for unconsolidated entities and noncontrolling interests. Adjustments for unconsolidated entities and noncontrolling interests will be calculated to reflect FFO on the same basis.

Normalized FFO Attributable to Common Stockholders ("Normalized FFO")

The Company defines Normalized FFO as Nareit FFO excluding the following income and expense items, without duplication: (a) gains and losses on derivatives, net and changes in the fair value of financial instruments; (b) the non-cash impact of income tax benefits or expenses; (c) gains and losses on extinguishment of debt, net including the write-off of unamortized deferred financing fees or additional costs, expenses, discounts, make-whole payments, penalties or premiums incurred as a result of early retirement or payment of our debt; (d) transaction, transition and restructuring costs; (e) amortization of other intangibles; (f) non-cash stock-based compensation expense; (g) net expenses or recoveries related to significant disruptive events; (h) the impact of expenses related to asset impairment and valuation allowances; (i) the financial impact of contingent consideration; (j) gains and losses on non-real estate dispositions and other normalizing items related to noncontrolling interests and unconsolidated entities; and (k) other items set forth in the Normalized FFO reconciliation included herein.

Nareit FFO and Normalized FFO presented herein may not be comparable to those presented by other companies, which may define similarly titled measures differently than the Company does. Nareit FFO and Normalized FFO should not be considered as alternatives to net income attributable to common stockholders (determined in accordance with GAAP) as indicators of the Company's financial performance or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company's liquidity, nor are they necessarily indicative of sufficient cash flow to fund all of the Company's needs. The Company believes that in order to facilitate a clear understanding of the consolidated historical operating results of the Company, Nareit FFO and Normalized FFO should be examined in conjunction with net income attributable to common stockholders as presented elsewhere herein.

NON-GAAP FINANCIAL MEASURES RECONCILIATION

Full Year 2026 Guidance as of July 29th, 20261

Net Income and FFO Attributable to Common Stockholders2

(In millions, except per share amounts; dollars in USD; totals may not sum due to rounding; unaudited) FY 2026 FY 2026 - Per Share Low High Low High Net income attributable to common stockholders $291 $317 $0.58 $0.63 Depreciation and amortization adjustments ...

View Comments